# Posterior reversible encephalopathy syndrome in severe leptospirosis: A case report

**Authors:** Thamalee Palliyaguru, Pramith Ruwanpathirana, Mythily Aravinthan, Dilshan Priyankara, Praveen Weeratunga

PMC · DOI: 10.1016/j.idcr.2025.e02330 · IDCases · 2025-07-26

## TL;DR

A 14-year-old boy with severe leptospirosis developed posterior reversible encephalopathy syndrome (PRES), a rare neurological complication.

## Contribution

This case report highlights PRES as an uncommon but important complication of severe leptospirosis.

## Key findings

- PRES occurred during the recovery phase of severe leptospirosis in a 14-year-old patient.
- Neurological symptoms resolved spontaneously within 24 hours, and the patient fully recovered.
- The case suggests clinicians should consider PRES in leptospirosis patients with acute encephalopathy or seizures.

## Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinico-radiological entity with diverse aetiologies. It presents with headache, altered sensorium, seizures, and visual disturbances and is characterised by symmetrical white matter changes on neuroimaging. An acute rise in the blood pressure is the commonest cause of PRES. We report a patient who developed PRES in the recovery phase of severe leptospirosis. We discuss the interplay of possible patho-mechanisms of PRES in leptospirosis.

A 14-year-old Sri Lankan male presented with a 5-day history of high-grade fever and myalgia and a 2-day history of oliguria. Physical examination was unremarkable. Leptospirosis was diagnosed using the microscopic agglutination test. During hospitalisation, he developed acute kidney injury and pulmonary haemorrhage, requiring mechanical ventilation and treatment with intravenous ceftriaxone and daily plasma exchange. Both complications resolved by day 13 of the illness. On day 14, he developed sudden-onset altered consciousness followed by a generalised tonic-clonic seizure. There were no signs of meningism, and serum glucose, calcium, magnesium, and sodium levels were within normal limits. Brain MRI demonstrated symmetrical T2/FLAIR hyperintensities in the bilateral parieto-occipital white matter, consistent with PRES. Blood pressure at the time was 140/90 mmHg. Cerebral angiography excluded vasculitis. Neurological symptoms resolved spontaneously within 24 h, and the patient recovered fully.

PRES is an uncommon complication of severe leptospirosis. Clinicians should consider this diagnosis in patients with leptospirosis who develop acute encephalopathy or seizures.

## Linked entities

- **Diseases:** leptospirosis (MONDO:0005825), Posterior reversible encephalopathy syndrome (MONDO:0044033), acute kidney injury (MONDO:0002492)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** cortical blindness (MESH:D019575), myalgia (MESH:D063806), Acute liver injury (MESH:D017114), endothelial injury (MESH:D057772), rhabdomyolysis (MESH:D012206), glomerulonephritis (MESH:D005921), Seizures (MESH:D012640), inflammatory (MESH:D007249), HIV (MESH:D015658), tonic-clonic convulsion (MESH:D004830), status epilepticus (MESH:D013226), liver injury (MESH:D017093), Infections (MESH:D007239), cytopenias (MESH:D006402), multiorgan dysfunction (MESH:D009102), hypertension (MESH:D006973), viral infections (MESH:D014777), gram (MESH:D016908), myocarditis (MESH:D009205), meningism (MESH:D008580), coagulopathy (MESH:D001778), Leptospirosis (MESH:D007922), oliguria (MESH:D009846), Vasogenic oedema (MESH:D001929), vessel occlusion (MESH:C536223), COVID-19 (MESH:D000086382), lupus nephritis (MESH:D008181), cerebral vasculitis (MESH:D020293), encephalopathy (MESH:D001927), Pulmonary haemorrhages (MESH:D006474), cerebral hyper and hypo-perfusion (MESH:D052456), pancreatitis (MESH:D010195), endothelial dysfunction (MESH:D014652), haemolysis (MESH:D006461), febrile illness (MESH:D005334), venous thrombosis (MESH:D020246), renal and autoimmune diseases (MESH:D007674), neurological deficits (MESH:D009461), neurological sequelae (MESH:D009422), white matter (MESH:D056784), malaria (MESH:D008288), headache (MESH:D006261), PRES (MESH:D054038), cytotoxic oedema (MESH:C536897), influenza (MESH:D007251), cytokine storm (MESH:D000080424), rickettsial infections (MESH:D012282), positive septicaemia (MESH:D018805), AKI (MESH:D058186), type 1 respiratory failure (MESH:D012131), icterus (MESH:D007565), aseptic meningitis (MESH:D008582), haemorrhages (MESH:D006470), swelling (MESH:D004487), vasculitis (MESH:D014657), papilledema (MESH:D010211), visual disturbances (MESH:D014786), neck stiffness (MESH:D006258), altered consciousness (MESH:D003244)
- **Chemicals:** magnesium (MESH:D008274), blood glucose (MESH:D001786), ceftriaxone (MESH:D002443), creatinine (MESH:D003404), labetalol (MESH:D007741), aldosterone (MESH:D000450), oxygen (MESH:D010100), sodium (MESH:D012964), potassium (MESH:D011188), glucose (MESH:D005947), Calcium (MESH:D002118)
- **Species:** Leptospira interrogans (species) [taxon 173], Homo sapiens (human, species) [taxon 9606], Mycoplasma (genus) [taxon 2093]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12320078/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12320078/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12320078/full.md

---
Source: https://tomesphere.com/paper/PMC12320078